Skip to search formSkip to main contentSkip to account menu

thymostimulin

Known as: active thymus factor, thymustimulin 
National Institutes of Health

Related topics

Related topics

4 relations

Broader (3)

Immunologic AdjuvantsInterferon InducersThymus Extracts

Narrower (1)

TP-1

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1996
1996
Thymostimulin treatment of hepatocellular carcinoma on liver cirrhosis.
Hepatocellular carcinoma (HCC) on liver cirrhosis (LC) is a neoplasm with a poor prognosis. Only 10-36% of patients have… 
1996
1996
The effects of thymostimulin on immunological function in patients with head and neck cancer.
Patients with head and neck carcinoma show deficits of cellular immunity, probably due to low molecular mass factors (LMMFs… 
1993
1993
Effectiveness of thymostimulin and study of lymphocyte-dependent antibacterial activity in children with recurrent respiratory infections.
Recurrent respiratory infections (RRI) consist of more relapsing acute respiratory infections than the ones expected for the age… 
1992
1992
Thymostimulin administration modulates polymorph metabolic pathway in patients with chronic obstructive pulmonary disease.
Several studies outline the imbalance of phagocyte functions in chronic obstructive pulmonary disease (COPD). In this regard… 
1990
1990
Stimulation of the immune response in outpatients with hepatocellular carcinomas by low doses of cyclophosphamide (LDCY), echinacea purpurea extracts (Echinacin) and thymostimulin.
Outpatients with inoperable far advanced hepato-cellular carcinomas (n = 5) were treated with LDCY--300 mg/m2 i.v. every 28 days… 
1989
1989
Effects of thymostimulin on chemotherapy-induced toxicity and long-term survival in small cell lung cancer patients.
The effects of hymostimulin on chemotherapy-induced toxicity and long-term survival were studied in 26 evaluable patients with… 
1984
1984
Postsurgical adjuvant treatment of malignant melanoma patients by the thymic factor thymostimulin.
37 patients with cutaneous malignant melanoma (MM) were randomized, after surgical removal of tumor, to either no further… 
1982
1982
The in vitro effect of a calf thymus extract (thymostimulin) on the immunologic parameters of patients with untreated Hodgkin's disease
The in vitro effect of a calf thymus extract, thymostimulin (TP‐1), on the E‐rosette‐forming capacity and on the PHA blastogenic… 
1982
1982
The in vivo effect of a thymic factor (thymostimulin) on immunologic parameters of patients with untreated Hodgkin's disease
The in vivo effect of a calf thymus extract (thymostimulin, TS) on the E‐rosetting capacity, PHA blastogenic response, serum… 
1981
1981
Effect of the thymic factor, thymostimulin (TP-1), on the survival rate of tumor-bearing mice.
The effect of treatment with the thymic factor thymostimulin (TP-1) on the survival rate of tumor-bearing mice was studied, using… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)